{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:51:44Z","timestamp":1791910304654,"version":"4.3.4"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129082","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:39:57Z","timestamp":1790350797000},"page":"129082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults"],"prefix":"10.1016","volume":"93","author":[{"given":"William","family":"Schaffner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Garc\u00eda","family":"Cenoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Vicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129082_bb0005","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.129082_bb0010","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.129082_bb0015","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0020","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0025","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/idr14040059","article-title":"Impact of COVID-19 on the changing patterns of respiratory syncytial virus infections","volume":"14","author":"Garg","year":"2022","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0035","unstructured":"World Health Organization Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. 2023. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic (accessed January 28, 2026)."},{"key":"10.1016\/j.vaccine.2026.129082_bb0040","article-title":"From emergency response to long-term management: the many faces of the endemic state of COVID-19","volume":"30","author":"Contreras","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2026.129082_bb0045","first-page":"185","article-title":"Vaccines against influenza: WHO position paper - May 2022","volume":"97","author":"World Health Organization","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.129082_bb0050","author":"Dugan"},{"key":"10.1016\/j.vaccine.2026.129082_bb0055","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0060","series-title":"Influenza (seasonal)","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0065","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.vaccine.2026.129082_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.15585\/mmwr.mm7240a2","article-title":"Disease severity of respiratory syncytial virus compared with COVID-19 and influenza among hospitalized adults aged \u226560 years - IVY Network, 20 U.S. states, February 2022\u2013May 2023","volume":"72","author":"Surie","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0075","series-title":"The age-specific impact of influenza on hospital admissions and mortality in five countries in Europe","author":"Nielen","year":"2010"},{"key":"10.1016\/j.vaccine.2026.129082_bb0080","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0085","author":"Center for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0090","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0095","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(23)00684-9","article-title":"Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study","volume":"24","author":"Xie","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.129082_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1113793","article-title":"Predisposing factors for admission to intensive care units of patients with COVID-19 infection-results of the German nationwide inpatient sample","volume":"11","author":"Keller","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.129082_bb0115","author":"Srinivasan"},{"key":"10.1016\/j.vaccine.2026.129082_bb0120","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.5888\/pcd18.210123","article-title":"Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021","volume":"18","author":"Kompaniyets","year":"2021","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12603-021-1611-9","article-title":"The impact of frailty on COVID-19 outcomes: a systematic review and meta-analysis of 16 cohort studies","volume":"25","author":"Yang","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.vaccine.2026.129082_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12877-021-02140-x","article-title":"Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19","volume":"21","author":"Walle-Hansen","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.vaccine.2026.129082_bb0135","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.17.1900199","article-title":"Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016","volume":"25","author":"Ohland","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.129082_bb0140","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/heartjnl-2013-304320","article-title":"Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study","volume":"99","author":"Macintyre","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.vaccine.2026.129082_bb0145","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0150","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.15585\/mmwr.mm7406a2","article-title":"Interim estimates of 2024-2025 seasonal influenza vaccine effectiveness - four vaccine effectiveness networks, United States, October 2024-February 2025","volume":"74","author":"Frutos","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0160","article-title":"Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data","volume":"60","author":"Faksova","year":"2026","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2026.129082_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15585\/mmwr.mm7406a1","article-title":"Interim estimates of 2024-2025 COVID-19 vaccine effectiveness among adults aged \u226518 years - VISION and IVY networks, September 2024-January 2025","volume":"74","author":"Link-Gelles","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0170","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0175","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0180","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0185","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.vaccine.2026.129082_bb0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/ph15030322","article-title":"COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy","volume":"15","author":"Domnich","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/vaccines13040335","article-title":"Innovations, challenges, and future prospects for combination vaccines against human infections","volume":"13","author":"Fatima","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0215","doi-asserted-by":"crossref","DOI":"10.2196\/57242","article-title":"COVID-19 vaccine preferences in general populations in Canada, Germany, the United Kingdom, and the United States: discrete choice experiment","volume":"10","author":"Salisbury","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2026.129082_bb0220","series-title":"Potential operational efficiencies of a combintaion influenza and COVID-19 vaccine in US pharmacies","author":"Sweeney","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0200","author":"Center for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0205","author":"Center for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0210","series-title":"Consumer and healthcare provider preferences for adult combination COVID-19 and influenza vaccines: results from a discrete choice study in France, Italy and Germany","author":"Servin","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13696998.2025.2462412","article-title":"US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines","volume":"28","author":"Poulos","year":"2025","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2026.129082_bb0335","series-title":"Preferences for a combination influenza and COVID-19 vaccine: results from a threshold technique study with consumers in the United Kingdom","article-title":"Presented at ISPOR","author":"Poulos","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129082_bb0340","series-title":"Preferences for a combination influenza and COVID-19 vaccine: results from a stated preference survey with consumers in the United States, United Kingdom, and Germany","author":"Poulos","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0225","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The value of childhood combination vaccines: from beliefs to evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129082_bb0230","first-page":"1","article-title":"Strategies to reduce errors associated with 2-component vaccines","volume":"35","author":"Samad","year":"2021","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.vaccine.2026.129082_bb0235","first-page":"S6","article-title":"Benefits of combination vaccines: effective vaccination on a simplified schedule","volume":"9","author":"Dodd","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vaccine.2026.129082_bb0240","first-page":"726","article-title":"Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries","volume":"81","author":"Drain","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.129082_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18147425","article-title":"The ecological footprint of COVID-19 mRNA vaccines: estimating greenhouse gas emissions in Germany","volume":"18","author":"Kurzweil","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2026.129082_bb0250","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/13696998.2024.2370177","article-title":"Vaccine preparation time, errors, satisfaction, and preference of prefilled syringes versus RSV vaccines requiring reconstitution: randomized, time and motion study","volume":"27","author":"Mehta","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2026.129082_bb0260","article-title":"Within-country inequality in COVID-19 vaccination coverage: a scoping review of academic literature","volume":"11","author":"Bergen","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0265","article-title":"Social determinants of health and vaccine uptake during the first wave of the COVID-19 pandemic: a systematic review","volume":"35","author":"Vardavas","year":"2023","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0270","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/00333549221123584","article-title":"COVID-19 vaccine initiation and dose completion during the SARS-CoV-2 delta variant surge in the United States, December 2020-October 2021","volume":"138","author":"Murthy","year":"2023","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3201\/eid2901.221151","article-title":"COVID-19 booster dose vaccination coverage and factors associated with booster vaccination among adults, United States, March 2022","volume":"29","author":"Lu","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0290","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0295","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0300","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.vaccine.2026.129082_bb0305","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0310","author":"Robert Koch Institut"},{"key":"10.1016\/j.vaccine.2026.129082_bb0315","author":"GOV.UK"},{"key":"10.1016\/j.vaccine.2026.129082_bb0320","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine co-administration in adults: an effective way to improve vaccination coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129082_bb0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/vaccines12020216","article-title":"Co-administration of influenza and COVID-19 vaccines: policy review and vaccination coverage trends in the European Union, UK, US, and Canada between 2019 and 2023","volume":"12","author":"Achterbergh","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0330","article-title":"Combining influenza and COVID-19 booster vaccination strategy to improve vaccination uptake necessary for managing the health pandemic: a systematic review and meta-analysis","volume":"11","author":"Tzenios","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0585","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0590","author":"UK Government"},{"key":"10.1016\/j.vaccine.2026.129082_bb0595","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr7202a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2023\u201324 influenza season","volume":"72","author":"Grohskopf","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2026.129082_bb0345","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(23)02467-4","article-title":"Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.129082_bb0350","author":"Joshi"},{"key":"10.1016\/j.vaccine.2026.129082_bb0355","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/13696998.2024.2400852","article-title":"Comparison of healthcare resource use and cost between influenza and COVID-19 vaccine coadministration and influenza vaccination only","volume":"27","author":"Mehta","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2026.129082_bb0360","series-title":"Projected public health impact of synchronized COVID-19 and influenza vaccination with a combination vaccine in U.S. older adults","author":"Fust","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0365","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/14760584.2024.2383343","article-title":"Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom","volume":"23","author":"Harrison","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129082_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-18694-5","article-title":"Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives","volume":"24","author":"de Fougerolles","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.129082_bb0375","series-title":"Co-seasonality of seasonal influenza and COVID-19 in the US, 2022-2024The European scientific working group on influenza. The European Scientific Working Group on Influenza (ESWI). Valencia, Spain","author":"Park","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129082_bb0380","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/infdis\/jiae507","article-title":"Combination seasonal vaccines for influenza, respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2, and other pathogens","volume":"231","author":"Dobrzynski","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0385","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0390","author":"Center for disease control and prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0395","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ije\/dyab081","article-title":"Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design","volume":"50","author":"Stowe","year":"2021","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129082_bb0400","series-title":"COVID-19 vaccines","author":"World Health Organization","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129082_bb0415","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40121-025-01135-0","article-title":"Optimal timing of vaccination: a narrative review of integrating strategies for COVID-19, influenza, and respiratory syncytial virus","volume":"14","author":"Bonanni","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.129082_bb0420","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2025.5646","article-title":"Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults \u226550 years: a randomized clinical trial","volume":"333","author":"Rudman Spergel","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.129082_bb0425","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1016\/j.vaccine.2023.06.038","article-title":"Intraseasonal waning immunity of seasonal influenza vaccine - a systematic review and meta-analysis","volume":"41","author":"Doyon-Plourde","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129082_bb0430","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cid\/ciab045","article-title":"Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, United States hospitalized adult influenza vaccine effectiveness network","volume":"73","author":"Ferdinands","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0435","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S1473-3099(25)00236-1","article-title":"Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial","volume":"25","author":"Chalkias","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0342382","article-title":"Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: a test-negative case-control study using the id.DRIVE platform","volume":"21","author":"Volkman","year":"2026","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.129082_bb0445","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2026.2675021","article-title":"Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults \u226550 years","volume":"22","author":"Kostanyan","year":"2026","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129082_bb0450","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129082_bb0455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eimce.2024.08.006","article-title":"New COVID-19 vaccination recommendations in Spain: optimizing for next seasons","volume":"43","author":"Arrazola","year":"2025","journal-title":"Enfermedades infecciosas y microbiologia clinica (English ed.)"},{"key":"10.1016\/j.vaccine.2026.129082_bb0460","author":"GOV.UK"},{"key":"10.1016\/j.vaccine.2026.129082_bb0465","author":"Gov.UK"},{"key":"10.1016\/j.vaccine.2026.129082_bb0470","unstructured":"Consejo Interterritorial Sistema Nacional de Salud COVID-19 vaccine recommendations 2025\u20132026, Spain. 2025. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/gripe_covid19\/docs\/recomendacionesVacunacionCovid19_2025_2006.pdf; [accessed August 5, 2025]."},{"key":"10.1016\/j.vaccine.2026.129082_bb0475","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1016\/S2214-109X(24)00092-5","article-title":"Facilitating the development of urgently required combination vaccines","volume":"12","author":"Hausdorff","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.129082_bb0480","author":"Food and Drug Administration"},{"key":"10.1016\/j.vaccine.2026.129082_bb0485","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/d41573-021-00176-7","article-title":"mRNA flu shots move into trials","volume":"20","author":"Dolgin","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129082_bb0490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/jiad541","article-title":"The potential benefits of delaying seasonal influenza vaccine selections for the northern hemisphere: a retrospective modeling study in the United States","volume":"230","author":"Lee","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129082_bb0495","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2336357","article-title":"Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines","volume":"20","author":"Russell","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129082_bb0500","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2026.129082_bb0505","first-page":"E107","article-title":"Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts","volume":"59","author":"Orsi","year":"2018","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2026.129082_bb0510","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0515","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0520","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129082_bb0525","author":"Moderna Inc"},{"key":"10.1016\/j.vaccine.2026.129082_bb0530","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2026.129082_bb0540","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bb0545","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bb0550","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bb0555","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bb0560","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bb0565","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2026.129082_bib596","unstructured":"Pfizer Press release. Pfizer and BioNTech provide update on mRNA-based combination vaccine program against influenza and COVID-19 in individuals 18-64 years of age. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-provide-update-mrna-based-combination; 2024. (accessed September 9, 2026)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:53Z","timestamp":1791908693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":113,"alternative-id":["S0264410X26008911"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129082"}}